ArticleNucleus (Austin, Tex.)2023

The farnesyl transferase inhibitor (FTI) lonafarnib improves nuclear morphology in ZMPSTE24-deficient fibroblasts from patients with the progeroid disorder MAD-B.

Kamsi O Odinammadu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.